+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pseudoexfoliation syndrome (PEX)--a systemic disorder

Pseudoexfoliation syndrome (PEX)--a systemic disorder

Klinika Oczna 111(4-6): 160-164

Pseudoexfoliation syndrome is an age-related elastosis. The current pathogenetic concept describes PEX as an elastic microfibrillopathy involving TGF-betal, oxidative stress and impaired cellular protection mechanisms as a key pathogenetic factors. Extracellular PEX material is produced, aggregated and accumulated in the anterior segment of the eye. It is also present in the skin, lungs, liver and other visceral organs. These findings suggest that pseudoexfoliation syndrome is a systemic disorder. It is also associated with coronary artery disease, hypertension, Alzheimer's disease and other cardio-vascular problems. The pseudoexfoliation syndrome has been found to be associated with higher mean intraocular pressure, secondary open-angle glaucoma, mature and nuclear cataract. Ocular depositions of pseudoexfoliation material can lead to many intraocular complications. That's why special attention is required before, during and after surgery.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 055265364

Download citation: RISBibTeXText

PMID: 19673450

Related references

Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations. Human Genomics 6: 22, 2012

Pseudoexfoliation syndrome Intraocular manifestation of a systemic disorder?. Experimental Eye Research 55(Suppl. 1): S68, 1992

Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder?. Archives of Ophthalmology 110(12): 1752-1756, 1992

Systemic high-sensitivity C-reactive protein level in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Journal of Glaucoma 19(6): 373-376, 2010

Progress of intraocular pressure before and after cataract surgery in case of pseudoexfoliation syndrome versus control group without pseudoexfoliation syndrome. Investigative Ophthalmology & Visual Science 38(4 Part 1-2): S175, 1997

Ocular and Systemic Pseudoexfoliation Syndrome. Yearbook of Ophthalmology 2007: 244-246, 2007

Ocular and systemic pseudoexfoliation syndrome. American Journal of Ophthalmology 141(5): 921-937, 2006

Systemic endothelial dysfunction in patients with pseudoexfoliation syndrome. Klinische Monatsblatter für Augenheilkunde 225(11): 963-967, 2008

Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmology 105(6): 951-968, 1998

Impaired systemic endothelial function in patients with pseudoexfoliation syndrome. International Heart Journal 47(1): 77-84, 2006

Pseudoexfoliation syndrome Further evidence of a systemic fibrillopathy with a major component of fibrillin 15. Investigative Ophthalmology & Visual Science 35(4): 1785, 1994

Chosen Vascular Risk Markers in Pseudoexfoliation Syndrome: An Age-Related Disorder. Journal of Ophthalmology 2017: 5231095, 2017

Prevalence of pseudoexfoliation syndrome and its association with ocular and systemic diseases in Eskisehir, Turkey. International Journal of Ophthalmology 10(1): 128-134, 2017

Role of an extracellular chaperone, Clusterin in the pathogenesis of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma. Experimental Eye Research 127: 69-76, 2014

Altered Balance Between Matrix Metalloproteinases And Their Inhibitors In Pseudoexfoliation Syndrome And Pseudoexfoliation Glaucoma. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 3369, 2002